OGG1 gene sequence variation in head and neck cancer patients in pakistan

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 10, 2011, Pages 2779-2783

  Mahjabeen, Ishrat ^a   Baig, Ruqia Mehmood ^a   Masood, Nosheen ^a   Sabir, Maimoona ^a   Malik, Faraz Arshad ^a   Kayani, Mahmood Akhtar ^a  

^a Department of Electrical Computer Engineering   (Pakistan)

Author keywords

Germline mutation; Head and neck cancer; Mutation analysis; OGG1; Polymorphism

Indexed keywords

EID: 84858234460     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Arai K, Morishita K, Shinmura K, et al (1997). Cloning of a human homolog of the yeast OGG1 gene that is involved in the repair of oxidative DNA damage. Oncogene, 14, 2857-2861.
2. Arai T, Kelly VP, Komoro K, et al (2003). Cell proliferation in liver of Mmh/ Ogg1-deficient mice enhances mutation frequency because of the presence of 8-hydroxyguanine in DNA. Cancer Res, 63, 4287-4292.
3. Baumgartner-Parzer S, Schulze E, Waldhäusl W, et al (2001). Mutational spectrum of the steroid 21-hydroxylase gene in Austria: identification of a novel missense mutation. J Clin Endocrinol Metab, 86, 4771-4775.
4. Bhurgi Y, Bhurgi A, Nishter S, et al (2006). Pakistan - country profile of cancer and cancer control. J Pak Med Assoc, 56, 124-130.
5. Blons H, Laurent-Puig P (2003). TP53 and head and neck neoplasms. Hum Mutat, 21, ??.
6. Bosch FX, Ritter D, Enders C, et al (2004). Head and neck tumor sites differ in prevalence and spectrum of p53 alterations but these have limited prognostic value. Int J Cancer, 111, 530-538.
7. Bruner SD, Norman DP Verdine GL (2000). Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA. Nature, 403, 859-866.
8. Bruner SD, Norman DP, Fromme JC, et al(2000). Structural and mechanistic studies on repair of 8-oxoguanine in mammalian cells. Cold Spring Harb Symp Quant Biol, 65, 103-111.
9. Campbell MK, Farrell SO (2009). Biochemistry. Thomson, Brooks/Cole. CA. USA.
10. Crowe DL (2002). Molecular pathology of head and neck cancer. Histol Histopathol, 17, 909-914.
11. De Stefani E, Boffetta P, Deneo-Pellegrini H, et al (2007). The effect of smoking and drinking in oral and pharyngeal cancers: a case-control study in Uruguay. Cancer Lett, 246, 282-289.
12. Friedberg EC, Walker GC, Siede W, et al (2006). DNA Repair and Mutagenesis. ASM Press, Washington, DC.
13. Hardie LJ, Briggs JA, Davidson LA, et al (2000). The effect of hOGG1 and glutathione peroxidase I genotypes and 3p chromosomal loss on 8-hydroxydeoxyguanosine levels in lung cancer. Carcinogenesis, 21, 167-172.
14. Hecht S S (2008). Progress and challenges in selected areas of tobacco carcinogenesis. Chem Res Toxicol, 21, 160-171.
15. Indu K (2009) Textbook of medical physiology. Elsevier, UP India.
16. Kohno T, Shinmura K, Tosaka M, et al (1998). Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene, 16, 3219-3225.
17. Kohno T, Shinmura K, Tosaka M, Tani M, et al. (1998). Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene, 16, 3219-25.
18. Lamerdin JE, Montgomery MA, Stilwagen SA, et al (1995). Genomic sequence comparison of the human and mouse XRCC1 DNA repair gene regions. Genomics, 25, 547-554.
19. Lheureux S, Lambert B, Krieger S, et al (2011). Two novel variants in the 3'UTR of the BRCA1 gene in familial breast and/or ovarian cancer. Breast Cancer Res Treat, 125, 885-891.
20. Martinez GR, Loureiro AP, Marques SA, et al (2003). Oxidative and alkylating damage in DNA. Mutat Res, 544, 115-127.
21. Minowa O, Arai T, Hirano M, et al (2000). Mmh/ Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice. Proc Natl Acad Sci. USA, 97, 4156-4161.
22. Mitra S, Izumi T, Boldogh I, et al (2002). Choreography of oxidative damage repair in mammalian genomes. Free Radic Biol Med, 33, 15-28.
23. Nash HM, Lu R, Lane WS, Verdine GL (1997). The critical active-site amine of the human 8-oxoguanine DNA glycosylase, hOgg1: direct identification, ablation and chemical reconstitution. Chem Biol, 4, 693-702.
24. Norman DP, Chung SJ, Verdine GL (2003). Structural and biochemical exploration of a critical amino acid in human 8-oxoguanine glycosylase. Biochemistry, 42,1564-1572.
25. Park YJ, Choi EY, Choi JY, et al (2001). Genetic changes of hOGG1 and the activity of oh8Gua glycosylase in colon cancer. Eur J Cancer, 37, 340-346.
26. Parker AR, Meally RN, Sahin F, et al (2003). Defective human MutY phosphorylation exists in colorectal cancer cell lines with wild-type MutY alleles. J Biol Chem, 278, 47937-47945.
27. Perez-Ordonez B, Beauchemin M, Jordan RC (2006). Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol, 59, 445-453.
28. Poulsen HE, Prieme H, Loft S (1998). Role of oxidative DNA damage in cancer initiation and promotion. Eur J Cancer Pre, 7, 9-16.
29. Radicella JP, Dherin C, Desmaze C, et al(1997). Cloning and characterization of hOGG1, a human homolog of the OGG1 gene of Saccharomyces cerevisiae. Proc. Natl Acad Sci USA, 94, 8010-8015.
30. Scharer OD, Jiricny J (2001). Recent progress in the biology, chemistry and structural biology of DNA glycosylases. BioEssays, 23, 270-281.
31. Sugimura H, Kohno T, Wakai K, et al (1999). hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomark Prev, 8, 669-674.
32. Valavanidis A, Vlachogianni T, Fiotakis K (2009). Tobacco smoke; involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int J Environ Res Public Healt, 6, 445-462.
33. Valko M, Rhodes CJ, Moncol J, et al (2006). Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact, 160, 1-40.
34. Vassallo R, Kroening PR, Parambil J, et al (2008). Nicotine and oxidative cigarette smoke constituents induce immune-modulatory and pro-inflammatory dendritic cell responses. Mol Immunol, 45, 3321-3329.
35. Vierhapper H, Bieglmayer C, Heinze G, et al (2004). Frequency of RET protooncogene mutations in patients with normal and with moderately elevated (50-100 pg/ml) pentagastrin-stimulated serum concentrations of calcitonin. Thyroid, 14, 580-583.
36. Vogelstein B, Kinzler KW (2002). The Genetic Basis of Human Cancer. McGraw-Hill, USA.
37. Werbrouck J, De Ruyck k, Duprez F, et al (2008). Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption. Mutat Res, 656, 74-81.
38. Xu J, Zheng SL, Turner A, et al (2002). Associations between hOGG1 sequence variants and prostate cancer susceptibility. Cancer Res, 62, 2253-2257.